Full text is available at the source.
Abstract
Rosacea is associated with an increase in proinflammatory microbial species and a decline in protective ones.
- The condition involves immune dysregulation, genetic factors, and issues with the skin's barrier.
- Both gut and skin microbiomes may influence skin inflammation and disease severity.
- Proinflammatory species like Demodex folliculorum and Staphylococcus epidermidis are more prevalent in rosacea patients.
- Protective species such as Cutibacterium acnes are found in reduced numbers in affected individuals.
- Current treatments aim to restore microbial balance to reduce inflammation and improve skin barrier function.
- Future research could focus on precision treatments targeting specific microbial and immune pathways.
Simplified